Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Guidepoint Qsight's new analytics tool examines treatment pairings, repeat visits, and cross-purchasing trends across medical aesthetics.